Oppenheimer downgraded Opthea (OPT) to Perform from Outperform.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPT:
- Opthea downgraded to Neutral from Buy at H.C. Wainwright
- CoreWeave initiated, Carvana upgraded: Wall Street’s top analyst calls
- Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
- Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
- Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns